By Year : Latest | All | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011
- 11 July 2023 Clarify the Information that SET asks investors to study the financial statements of NUSA
- 11 July 2023 SET recommends the investors to study NUSA's financial statements and monitor the company's clarification
- 31 May 2023 New shares of NUSA to be traded on June 1, 2023
- 25 May 2023 Report on the results of the Exercise of NUSA-W4 (F53-5)
- 17 May 2023 Financial Statement Quarter 1/2023 (Reviewed)
- 16 May 2023 Notification of change of company secretary
- 16 May 2023 Report the progress on the action of the removal of the conflict of Interest in the Nusasiri Group
- 16 May 2023 Explanation in the event that English version of the financial statements for 1st Quarter ending 31st March 2023 is delayed
- 16 May 2023 Management Discussion and Analysis Quarter 1 Ending 31 Mar 2023
- 16 May 2023 Financial Performance Quarter 1 (F45) (Reviewed)
- 12 May 2023 Disclosure of the Minute of the 2023 Annual General Meeting of Shareholders on the Company's website
- 08 May 2023 Form to Report on Names of Members and Scope of Work of the Audit Committee (F24-1)
- 03 May 2023 Notify additional company holidays and cancel holidays
- 28 April 2023 Shareholders meeting's resolution
- 21 April 2023 Additional clarification in the invitation letter for the 2023 Annual General Meeting of Shareholders
- 21 April 2023 Opinion of the Board of Directors on IFA's opinion
- 19 April 2023 21 April 2023 is the last trading day of NUSA-W4
- 17 April 2023 Opinion of the Independent Financial Advisor on the transaction of Ratification of the Connected Transactions
- 29 March 2023 Adding an agenda for the 2023 AGM of Shareholders to approve issuance and allocation of warrants to purchase the Company's ordinary shares (NUSA-W5) and approve decrease-increase of the Company's registered capital (Revised 6)
- 29 March 2023 Adding an agenda for the 2023 AGM of Shareholders to approve issuance and allocation of warrants to purchase the Company's ordinary shares (NUSA-W5) and approve decrease-increase of the Company's registered capital (Revised 5)